Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Mol Med ; 50(2): e450, 2018 02 23.
Article in English | MEDLINE | ID: mdl-29472701

ABSTRACT

The gut microbiota has an important role in the gut barrier, inflammation and metabolic functions. Studies have identified a close association between the intestinal barrier and metabolic diseases, including obesity and type 2 diabetes (T2D). Recently, Akkermansia muciniphila has been reported as a beneficial bacterium that reduces gut barrier disruption and insulin resistance. Here we evaluated the role of A. muciniphila-derived extracellular vesicles (AmEVs) in the regulation of gut permeability. We found that there are more AmEVs in the fecal samples of healthy controls compared with those of patients with T2D. In addition, AmEV administration enhanced tight junction function, reduced body weight gain and improved glucose tolerance in high-fat diet (HFD)-induced diabetic mice. To test the direct effect of AmEVs on human epithelial cells, cultured Caco-2 cells were treated with these vesicles. AmEVs decreased the gut permeability of lipopolysaccharide-treated Caco-2 cells, whereas Escherichia coli-derived EVs had no significant effect. Interestingly, the expression of occludin was increased by AmEV treatment. Overall, these results imply that AmEVs may act as a functional moiety for controlling gut permeability and that the regulation of intestinal barrier integrity can improve metabolic functions in HFD-fed mice.


Subject(s)
Cell Membrane Permeability , Extracellular Vesicles/metabolism , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Tight Junctions/metabolism , Verrucomicrobia/metabolism , Animals , Biodiversity , Biomarkers , Caco-2 Cells , Diabetes Mellitus, Type 2/metabolism , Diet, High-Fat , Feces/microbiology , Gastrointestinal Microbiome , Humans , Mice
2.
Clin Endocrinol (Oxf) ; 72(1): 26-31, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19438903

ABSTRACT

OBJECTIVE: To explore the relationship of insulin resistance (IR) and adipokines (leptin, adiponectin, RBP4) to anti-Mullerian hormone (AMH) levels in women without polycystic ovary syndrome (PCOS). DESIGN/PATIENTS/MEASUREMENTS: We recruited 120 healthy, reproductive age women without PCOS. An overnight fasting blood draw, anthropometric measurements, analyses of serum levels of AMH, adipokines (leptin, adiponectin and RBP4) and total testosterone, a homeostasis model assessment for insulin resistance (HOMA-IR) and a transvaginal ultrasound scan were performed between the third and fifth day of their spontaneous menstrual cycles. RESULTS: Higher HOMA-IR levels were associated with lower levels of AMH. After adjustment for age, serum AMH levels negatively correlated with insulin, fasting glucose, HOMA-IR and RBP4. However, a positive correlation was identified between serum AMH and adiponectin. A final multiple stepwise linear regression demonstrated that HOMA-IR was independently associated with AMH. CONCLUSION: An independent relationship exists between HOMA-IR and AMH in women without PCOS, possibly due to the effect of abnormal insulin action on AMH secretion by granulosa cells.


Subject(s)
Anti-Mullerian Hormone/blood , Insulin Resistance , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/metabolism , Adiponectin/blood , Adult , Female , Humans , Insulin/blood , Insulin/metabolism , Insulin Resistance/physiology , Leptin/blood , Polycystic Ovary Syndrome/epidemiology , Regression Analysis , Retinol-Binding Proteins, Plasma/analysis
SELECTION OF CITATIONS
SEARCH DETAIL